Literature DB >> 2104259

Biocompatibility of hemodialysis membranes.

A K Cheung1.   

Abstract

Exposure of blood to hemodialysis membranes results in numerous interactions between the blood elements and the membrane. Transformation and adsorption of plasma proteins (such as complement) and activation of blood cells (such as neutrophils and monocytes) have been studied most extensively by nephrologists in recent years. There is no consensus on the definition of biocompatibility for dialyzer membranes. An operational definition of biocompatibility is the lack of any perturbation of blood constituents. According to this "inert surface" definition, a membrane (for example, one that adsorbs beta 2-microglobulin) can be considered as bioincompatible and yet desirable. Because of the multitude of blood-membrane interactions that may occur during hemodialysis, multiple criteria for biocompatibility needs to be applied in the classification of membranes. A certain bioincompatible phenomenon can be further classified as beneficial or deleterious depending on its biological effects as well as its acute and chronic impacts on the dialysis patient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104259     DOI: 10.1681/ASN.V12150

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

1.  Interface processes between iron containing aluminosilicate systems and simulated body fluid enriched with protein.

Authors:  K Magyari; O Popescu; V Simon
Journal:  J Mater Sci Mater Med       Date:  2010-03-12       Impact factor: 3.896

Review 2.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

Review 3.  Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.

Authors:  Nans Florens; Fitsum Guebre-Egziabher; L Juillard
Journal:  J Nephrol       Date:  2021-04-10       Impact factor: 3.902

Review 4.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  In vivo evaluation of the biocompatibility of surface modified hemodialysis polysulfone hollow fibers in rat.

Authors:  Ganpat J Dahe; Sachin S Kadam; Siddharth S Sabale; Dattatray P Kadam; Laxman B Sarkate; Jayesh R Bellare
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

Review 6.  Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.

Authors:  Christian Nusshag; Markus A Weigand; Martin Zeier; Christian Morath; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-06-28       Impact factor: 5.923

7.  Acute effects of haemodialysis on circulating microparticles.

Authors:  Philip de Laval; Fariborz Mobarrez; Tora Almquist; Liina Vassil; Bengt Fellström; Inga Soveri
Journal:  Clin Kidney J       Date:  2018-10-30

8.  Does the extracorporeal circulation worsen anemia in hemodialysis patients? Investigation with advanced microscopes of red blood cells drawn at the beginning and end of dialysis.

Authors:  Dimosthenis Stamopoulos; Nerantzoula Bakirtzi; Efthymios Manios; Eirini Grapsa
Journal:  Int J Nanomedicine       Date:  2013-10-11

9.  Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients.

Authors:  Louise Schilder; S Azam Nurmohamed; Pieter M ter Wee; Nanne J Paauw; Armand R J Girbes; Albertus Beishuizen; Robert H J Beelen; A B Johan Groeneveld
Journal:  BMC Nephrol       Date:  2014-01-17       Impact factor: 2.388

10.  Proteomics investigation of the changes in serum proteins after high- and low-flux hemodialysis.

Authors:  Shuai Han; Kaiguang Yang; Hong Zhu; Jianhui Liu; Lihua Zhang; Jiuyang Zhao
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.